Twinning for excellence to strategically advance research
in carcinogenesis and cancer.
The number of cancer cases in Europe is increasing each year, regardless of age, gender or social status, placing an enormous burden on health systems, patients, families and society in general.
As carcinogenesis is extremely heterogeneous, dynamic and complex system, holistic approaches that can analyse complex cellular and molecular interactions during cancer initiation and progression are crucial for the establishment of the basis for new prevention strategies and personalized anticancer treatments.
Applications towards designing in vitro, ex vivo and in vivo systems to reproduce cancer complexity and patient-specific tumours are increasingly investigated. Novel techniques in single-cell proteomics and spatial transcriptomics that enable visualization of cellular and molecular composition of tumours allow us to develop new personalized treatments for cancer patients.
in the Cutcancer project, combined with ongoing substantial NIB infrastructural advances and significant research equipment upgrades, NIB will improve research knowledge and methodology in cancer research and foster field networking.
Discover most recent news and events.
Open access: Immune-modulating effects on tumor draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC Ezgi B Ulas, Sofie J…
Open access: Targeting cystatin F activation enhances NK cell cytotoxicity in glioblastoma models Emanuela Senjor, Anamarija Habič, Urban Švajger, Ana Mitrović, Matic Proj, Andrej Porčnik, Borut…
Open access: Heterogenous mitochondrial ultrastructure and metabolism of human glioblastoma cells: differences between stem like and differentiated cancer cells in response to chemotherapy Urban Bogataj, Metka…
Open access: Exploring the genotoxic potential of Bisphenol A and its emerging alternatives in an advanced in vitro 3D zebrafish hepatic cell model Alja Štern a…
On 3 December 2025, the final, third annual project meeting was held online and was attended by all partners of the CutCancer consortium. The partners reviewed…
Click Here
Industry Webinar Recap: Advancing GBM Research with Targeted Expression Profiling In a recent industry webinar organized by Standard BioTools, Dr. Barbara Breznik shared groundbreaking insights into…
An online workshop was held via Zoom, bringing together experts from three leading institutions (National Institute of Biology (NIB), Stockholm University (SU) and VU University Medical Center (VUmc).…
New methodological approaches and opportunities for improved human health and progress in medicine for MSc students from the Faculty of Pharmacy. As part of the CutCancer…
Discover our partners, which helps us fight cancer.
